Exposure to methyl isobutyl ketone: toxicokinetics and occurrence of irritative and CNS symptoms in man.
The toxicokinetics as well as irritative effects and CNS symptoms of methyl isobutyl ketone (MIBK) were studied in human volunteers during inhalation exposure. The volunteers were exposed (2h, 50 W) in an exposure chamber on four different occasions to about 10, 100 and 200 mg/m3 MIBK and to a combination of about 100 mg/m3 MIBK and 150 mg/m3 toluene. The relative pulmonary uptake of MIBK was about 60% and the total uptake increased linearly with increasing exposure concentration. The concentration of MIBK in blood rose rapidly after the onset of exposure and no plateau level was reached during exposure. No tendency for saturation kinetics could be observed within the dose interval and the apparent blood clearance was 1.61/h/kg at all exposure levels. The concentration of unchanged MIBK in the urine after exposure was proportional with the total uptake. Only 0.04% of the total MIBK dose was eliminated unchanged via the kidneys within 3 h post exposure. The concentrations of the metabolites 4-hydroxy-4-methyl-2-pentanone and 4-methyl-2-pentanol were below the detection limit (5 nmol/l). Irritative and CNS symptoms occurred during exposure. The degree of both irritative and CNS symptoms increased during exposure to 100 and 200 mg/m3 compared with 10 mg/m3, but combination exposure with toluene exhibited the most pronounced effect. There were no significant effects from exposure on the performance of a simple reaction time task or a test of mental arithmetic.
Hjelm
E W
EW
Division of Work- and Environmental Physiology, National Institute of Occupational Health, Solna, Sweden.
Hagberg
M
M
Iregren
A
A
Löf
A
A
D000280:Administration, Inhalation; D000328:Adult; D000339:Affect / Q000187:drug effects*; D006207:Half-Life; D006801:Humans; D007659:Ketones / Q000493:pharmacokinetics*; D008297:Male; D008742:Methyl n-Butyl Ketone / Q000493:pharmacokinetics* / Q000633:toxicity; D011930:Reaction Time / Q000187:drug effects*; D012997:Solvents / Q000493:pharmacokinetics* / Q000633:toxicity; D014050:Toluene / Q000493:pharmacokinetics / Q000633:toxicity
D007659:Ketones; D012997:Solvents; D014050:Toluene; D008742:Methyl n-Butyl Ketone; C005458:methyl isobutyl ketone